Michelle Robertson - Insider Trading & Ownership

Location
C/O Momenta Pharmaceuticals, Inc., 301 Binney Street, Cambridge, MA
Summary
The estimated net worth of Michelle Robertson is at least $1.78M dollars as of May 27, 2025. Michelle Robertson is the EVP, CHIEF FINANCIAL OFFICER of Editas Medicine, Inc. and owns shares of Editas Medicine, Inc. (EDIT) stock worth about $1.16M. Michelle Robertson is the EVP, Chief Financial Officer of GERON CORP and owns shares of GERON CORP (GERN) stock worth about $501K. Michelle Robertson is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $116K.
Signature
/s/ Daniel Calkins, Attorney in Fact
All Insider Reports
All Insider Reports

Ownership of Michelle Robertson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EDIT Editas Medicine, Inc. Evp, Chief Financial Officer $1.16M May 11, 2023
GERN, GERNW GERON CORP EVP, Chief Financial Officer $501K Feb 18, 2025
VSTM Verastem, Inc. Director $116K May 22, 2025

Insider Transactions Reported by Michelle Robertson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.